• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

米非司酮治疗可改善自发性肺癌小鼠的生存时间和质量。

Mifepristone treatment improves length and quality of survival of mice with spontaneous lung cancer.

机构信息

The University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School at Camden, Cooper Hospital University Medical Center, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Camden, NJ, USA.

出版信息

Anticancer Res. 2010 Jan;30(1):119-22.

PMID:20150625
Abstract

BACKGROUND

There are data showing that human leukemia cell lines have mRNA for an immunomodulatory protein found in normal pregnancy that is stimulated by progesterone. One of the functions of this progesterone-induced blocking factor (PIBF) is to suppress natural killer cell activity. Mifepristone has not only been shown to down-regulate PIBF expression by human leukemic cell lines but has also been shown to prolong and improve the length of life of mice with spontaneous leukemia.

MATERIALS AND METHODS

Mifepristone at 0.3 mg was gavaged three times weekly from 8 weeks vs. olive oil in the controls.

RESULTS

The survival at one year for mice treated with mifepristone was 57.6% vs. 26.6% for controls (p=0.056). There were 66.7% of mice treated with mifepristone with no sick days whereas there was not one control mouse that did not become sick within the first year. The mean number of days sick was 11.6 for mifepristone vs. 57.6 days for controls (p=0.05) and 66.7% of the survival group had no sick days vs. none of the controls.

CONCLUSION

These data suggest a possible novel cancer therapy using progesterone receptor antagonist drugs even in tumors not known to have progesterone receptors to try to change the tumor microenvironment and re-activate suppressed natural killer cells.

摘要

背景

有数据表明,人类白血病细胞系存在一种在正常妊娠中发现的免疫调节蛋白的 mRNA,该蛋白受到孕激素的刺激。这种孕激素诱导的阻断因子(PIBF)的功能之一是抑制自然杀伤细胞的活性。米非司酮不仅显示出通过人白血病细胞系下调 PIBF 表达,而且还显示出延长和改善自发性白血病小鼠的寿命。

材料和方法

从第 8 周开始,每周三次通过灌胃给予米非司酮 0.3mg,与对照组中的橄榄油进行比较。

结果

接受米非司酮治疗的小鼠在一年内的存活率为 57.6%,而对照组为 26.6%(p=0.056)。接受米非司酮治疗的小鼠中有 66.7%没有生病的日子,而对照组中没有一只老鼠在第一年不生病。米非司酮组生病的平均天数为 11.6 天,而对照组为 57.6 天(p=0.05),并且在存活组中,有 66.7%的小鼠没有生病的日子,而对照组中没有一只老鼠。

结论

这些数据表明,即使在未知具有孕激素受体的肿瘤中,使用孕激素受体拮抗剂药物也可能是一种新的癌症治疗方法,试图改变肿瘤微环境并重新激活被抑制的自然杀伤细胞。

相似文献

1
Mifepristone treatment improves length and quality of survival of mice with spontaneous lung cancer.米非司酮治疗可改善自发性肺癌小鼠的生存时间和质量。
Anticancer Res. 2010 Jan;30(1):119-22.
2
Mifepristone treatment improves length and quality of survival of mice with spontaneous leukemia.米非司酮治疗可改善自发性白血病小鼠的生存时长和生存质量。
Anticancer Res. 2009 Aug;29(8):2977-80.
3
Support for the hypothesis that successful immunotherapy of various cancers can be achieved by inhibiting a progesterone associated immunomodulatory protein.支持以下假设:通过抑制一种与孕酮相关的免疫调节蛋白,可以实现对各种癌症的成功免疫治疗。
Med Hypotheses. 2009 Jan;72(1):87-90. doi: 10.1016/j.mehy.2008.05.042. Epub 2008 Oct 7.
4
Progesterone receptor antagonist therapy has therapeutic potential even in cancer restricted to males as evidenced from murine testicular and prostate cancer studies.孕激素受体拮抗剂治疗具有治疗潜力,即使在局限于男性的癌症中也是如此,这从鼠睾丸和前列腺癌研究中得到了证明。
Anticancer Res. 2010 Dec;30(12):4921-3.
5
Evidence that progesterone receptor antagonists may help in the treatment of a variety of cancers by locally suppressing natural killer cell activity.有证据表明,孕激素受体拮抗剂可能通过局部抑制自然杀伤细胞活性来帮助治疗多种癌症。
Clin Exp Obstet Gynecol. 2007;34(4):207-11.
6
Mifepristone may halt progression of extensively metastatic human adenocarcinoma of the colon - case report.米非司酮可能会阻止广泛转移的人类结肠腺癌进展——病例报告。
Anticancer Res. 2009 May;29(5):1611-3.
7
The antiabortive effect of progesterone-induced blocking factor in mice is manifested by modulating NK activity.孕酮诱导阻断因子在小鼠中的抗流产作用通过调节自然杀伤细胞活性来体现。
Cell Immunol. 1997 May 1;177(2):194-9. doi: 10.1006/cimm.1997.1090.
8
[Inhibitive effects of mifepristone on growth of breast cancer: experiment with animal model].米非司酮对乳腺癌生长的抑制作用:动物模型实验
Zhonghua Yi Xue Za Zhi. 2008 Feb 26;88(8):559-63.
9
NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).柳氮磺胺吡啶(CAS编号:599-79-1)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学与致癌性研究(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 1997 May;457:1-327.
10
Efficacy of the progesterone receptor antagonist mifepristone for palliative therapy of patients with a variety of advanced cancer types.米非司酮作为孕激素受体拮抗剂对多种晚期癌症患者的姑息治疗的疗效。
Anticancer Res. 2010 Feb;30(2):623-8.

引用本文的文献

1
Prognostic value of progesterone receptor expression in non-small cell lung cancer tissue.非小细胞肺癌组织中孕激素受体表达的预后价值
Ir J Med Sci. 2025 Mar 21. doi: 10.1007/s11845-025-03917-4.
2
A Hypothetical Model Suggesting Some Possible Ways That the Progesterone Receptor May Be Involved in Cancer Proliferation.一个假设模型,提示孕激素受体可能参与癌症增殖的一些可能方式。
Int J Mol Sci. 2021 Nov 16;22(22):12351. doi: 10.3390/ijms222212351.
3
Postoperative Natural Killer Cell Dysfunction: The Prime Suspect in the Case of Metastasis Following Curative Cancer Surgery.
术后自然杀伤细胞功能障碍:根治性癌症手术后转移病例的主要嫌疑人。
Int J Mol Sci. 2021 Oct 21;22(21):11378. doi: 10.3390/ijms222111378.
4
Progesterone receptor isoform B expression in pulmonary neuroendocrine cells decreases cell proliferation.孕激素受体 B 异构体在肺神经内分泌细胞中的表达可降低细胞增殖。
J Steroid Biochem Mol Biol. 2019 Jun;190:212-223. doi: 10.1016/j.jsbmb.2019.03.022. Epub 2019 Mar 26.
5
Progesterone receptor (PR) polyproline domain (PPD) mediates inhibition of epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer cells.孕激素受体(PR)的多脯氨酸结构域(PPD)介导非小细胞肺癌细胞中表皮生长因子受体(EGFR)信号传导的抑制。
Cancer Lett. 2016 May 1;374(2):279-91. doi: 10.1016/j.canlet.2016.02.014. Epub 2016 Feb 15.
6
Significance of the progesterone receptor and epidermal growth factor receptor, but not the estrogen receptor, in chemically induced lung carcinogenesis in female A/J mice.孕激素受体和表皮生长因子受体而非雌激素受体在化学诱导的雌性A/J小鼠肺癌发生中的意义
Oncol Lett. 2014 Dec;8(6):2379-2386. doi: 10.3892/ol.2014.2559. Epub 2014 Sep 24.
7
Cells isolated from human glioblastoma multiforme express progesterone-induced blocking factor (PIBF).从多形性胶质母细胞瘤中分离出的细胞表达孕酮诱导阻断因子(PIBF)。
Cell Mol Neurobiol. 2014 May;34(4):479-89. doi: 10.1007/s10571-014-0031-3. Epub 2014 Jan 29.
8
Estrogen signaling in lung cancer: an opportunity for novel therapy.肺癌中的雌激素信号:新型治疗的机会。
Cancers (Basel). 2012 Sep 25;4(4):969-88. doi: 10.3390/cancers4040969.
9
The role of estrogen, progesterone and aromatase in human non-small-cell lung cancer.雌激素、孕激素和芳香化酶在人类非小细胞肺癌中的作用。
Lung Cancer Manag. 2012 Dec;1(4):259-272. doi: 10.2217/lmt.12.44.
10
Cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamics.米非司酮诱导人转移性癌细胞的细胞静止和形态变化涉及细胞骨架丝状肌动蛋白的重组和细胞黏附动力学的损害。
BMC Cancer. 2013 Jan 26;13:35. doi: 10.1186/1471-2407-13-35.